Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1329, 2002-01, pp. : 7-9
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Efalizumab: durable benefits in plaque psoriasis
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
Access to resources
Recommend
Efalizumab effective for plaque psoriasis in Latin America
Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. :
Etanercept, efalizumab repair QOL in chronic plaque psoriasis
Inpharma, Vol. 1, Iss. 1456, 2004-01 ,pp. :
Etanercept, efalizumab repair QOL in chronic plaque psoriasis
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 463, 2004-01 ,pp. :
Efalizumab withdrawal/etanercept: Erythrodermic flare of plaque psoriasis: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1220, 2008-01 ,pp. :